By AuntMinnie.com staff writers

September 18, 2019 -- The U.S. Food and Drug Administration (FDA) has approved the opening of a cyclotron facility at the Mayor Clinic in Jacksonville, FL.

The cyclotron will be used to produce nuclear medicine radiopharmaceuticals such as carbon-11 (C-11) choline for imaging recurrent prostate cancer; F-18 FDG for cancer, cardiac, and neurological imaging; nitrogen-13 (N-13) ammonia for cardiac imaging; and F-18 sodium fluoride (NaF) for skeletal metastatic disease.

The facility can expand production to include future FDA-approved radiopharmaceuticals, the Mayo Clinic said. The cyclotron is the only facility in the region to offer investigational PET radiopharmaceuticals for use in clinical practice and research.


Copyright © 2019 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: